Investors find Mylan easy pill to swallow with juice
US pharmaceuticals company Mylan made its third visit to the euro corporate bond market in three years on Wednesday when it sold a €500m seven year deal with a €1.3bn order book.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: